The anti-viral immune response to COVID-19

Get full text

Understanding statistics in epidemics and pandemics lessons learned from COVID-19 /

Get full text

The End TB Strategy towards TB elimination, part 2 /

Get full text
Series

Tuberculosis and COVID-19

Get full text
Series

Medical decision-making in acute care treatment and planning /

Get full text

The complement system in innate and adaptive immunity part 2 of 2, diseases mediated by the complement system /

Get full text
Series

The history of infectious disease an overview and warning /

Get full text

Reaching the missing millions through public-private mix (PPM) for TB prevention and care

Get full text
Series

Leprosy epidemiology, pathology, immunology, prevention of disability and stigma /

Get full text
Series

Lessons from U.S. COVID hospital crisis

Get full text

Biobanks and their role in biomedical research

Get full text

Ethics and drug development

Get full text

International biobanking overview of key practices and policies /

Get full text
Series

The Omicron variant a South African perspective /

Get full text

COVID-19 the anti-viral immune response /

Get full text
Series

New concepts in the management of CAP a focus on severe illness. Part 1 of 2, Treatment and therapies /

Get full text
Series

New concepts in the management of CAP a focus on severe illness. Part 2 of 2, MRSA and MDR pathogens /

Get full text
Series

Updates on the management of difficult asthma in school-aged children

Get full text
Series

Studying immune responses "one cell at a time"

Get full text
Series (Periodic reports)
Series (Immune system)

Changes in innate and adaptive immunity during human ageing part 2 of 2 /

Get full text
Series